Future Medicinal Chemistry
Overview
'Future Medicinal Chemistry' is a peer-reviewed journal that focuses on the latest advancements in the field of medicinal chemistry. It covers a wide range of topics including drug discovery, design, synthesis, and optimization of novel therapeutic agents. The journal provides a platform for researchers and scientists to share their innovative approaches and strategies for developing future medicines to combat various diseases and improve patient outcomes.
Details
Details
Abbr.
Future Med Chem
Start
2009
End
Continuing
Frequency
Twenty-four issues a year, 2018-
p-ISSN
1756-8919
e-ISSN
1756-8927
Country
United Kingdom
Language
English
Metrics
Metrics
h-index / Ranks: 3682
90
SJR / Ranks: 8052
561
CiteScore / Ranks: 3323
6.50
JIF / Ranks: 2095
4.2
Recent Articles
1.
Bargakshatriya R, Pramanik S
Future Med Chem
. 2025 Mar;
:1-4.
PMID: 40085509
No abstract available.
2.
Gabr B, Shalabi A, Said M, George R
Future Med Chem
. 2025 Mar;
:1-21.
PMID: 40079157
The rapidly growing interest in the literature about the anticancer activity of 3,5-disubstituted pyrazolines and their promising therapeutic potentials/pharmacological properties, supported by the number of pyrazoline derivatives currently in clinical...
3.
4.
Ge Z, Fan Z, He W, Zhou G, Zhou Y, Zheng M, et al.
Future Med Chem
. 2025 Mar;
:1-16.
PMID: 40065567
(rat sarcoma) is one of the most frequently mutated gene families in cancer, encoding proteins classified as small GTPases. Mutations in RAS proteins result in abnormal activation of the RAS...
5.
Loy T, Schols D, De Jonghe S
Future Med Chem
. 2025 Mar;
:1-3.
PMID: 40065503
No abstract available.
6.
Rizzo C, Palumbo Piccionello A
Future Med Chem
. 2025 Mar;
:1-2.
PMID: 40047066
No abstract available.
7.
Giarolla J, Holdaway K, Nazari M, Aiad L, Sarkar B, Georg G
Future Med Chem
. 2025 Mar;
17(5):607-627.
PMID: 40034037
The review discusses progress in discovering cyclin-dependent kinase 2 (CDK2) inhibitors for cancer treatment and their potential for male contraception. It summarizes first-, second-, and third-generation CDK inhibitors and selective...
8.
Myrsing E, Mouli H, Nikhil P, Deepali , Sahu A, Jana A, et al.
Future Med Chem
. 2025 Mar;
17(5):513-528.
PMID: 40028717
Aim: This study investigates the anti-proliferative potential and possible molecular mechanisms of 3-(2-furoyl)-indole derivatives against HepG2. Method: Identified hit compounds (4a, 4b, 4c) using MTT screening, were further investigated for...
9.
Bhatia N, Kumar S, Goyal L, Thareja S
Future Med Chem
. 2025 Feb;
:1-4.
PMID: 40008677
No abstract available.
10.
Bouria H, Alliouche H, Chouiter M, Belfaitah A, Pacheco T, Gala V, et al.
Future Med Chem
. 2025 Feb;
17(5):543-555.
PMID: 40008604
Aim: This work explores the synthesis of new bi-heterocyclic hybrid compounds based on quinoline ring and investigates their potential as anticancer agents. Materials & Methods: The novel fused quinoline-thiazolo[3,2-a] benzimidazole-3(2 ...